Person:
EYİGÖR, ÖZHAN

Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

OrgUnit Logo
Organizational Unit

Job Title

Last Name

EYİGÖR

First Name

ÖZHAN

Name

Filters

20191
Reset filters

Settings

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Publication
    Glutamatergic activation of A1 and A2 noradrenergic neurons in the rat brain stem
    (Medicinska Naklada, 2019-07-10) Gök-Yurtseven, Duygu; Kafa, İlker M.; Minbay, Zehra; Eyigör, Özhan; GÖK YURTSEVEN, DUYGU; KAFA, İLKER MUSTAFA; MİNBAY, FATMA ZEHRA; EYİGÖR, ÖZHAN; Bursa Uludağ Üniversitesi/Fen Bilimleri Enstitüsü/Histoloji Bölümü ve Embriyoloji Bilim Dalı.; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Anatomi Anabilim Dalı.; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Histoloji ve Embriyoloji Anabilim Dalı.; 0000-0001-8309-0934; 0000-0003-3463-7483; AAW-4867-2021; AAG-7125-2021; ABE-5128-2020; ABC-1475-2020
    Aim To analyze the effects of glutamatergic agonists and antagonists on the activation of the A1 and A2 noradrenergic neurons localized in caudal ventrolateral medulla and nucleus tractus solitarii, respectively.Methods Rats were injected with glutamatergic agonists - kainic acid, alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), or N-methyl-D-aspartic acid (NMDA), and the brain sections were prepared for immunohistochemistry. Before agonist injections, antagonists - 6-cyano-7-nitroquinoxaline-2,3-dione or dizocilpine were administered. The expression of c-Fos, as the neuronal activation marker, and tyrosine hydroxylase (TH), as the marker of noradrenergic neurons was assessed with dual immunohistochemistry. The percentage of c-Fos-positive noradrenergic neurons relative to all TH-positive neurons in the respective areas of the brain stem was calculated.Results All three glutamatergic agonists significantly increased the number of the c-Fos-positive noradrenergic neurons in both the A1 and A2 area when compared with control animals. Kainic acid injection activated about 57% of TH-positive neurons in A1 and 40% in A2, AMPA activated 26% in A1 and 38% in A2, and NMDA 77% in A1 and 22% in A2. The injections of appropriate glutamatergic antagonists greatly decreased the number of activated noradrenergic neurons.Conclusion Our results suggest that noradrenergic neurons are regulated and/or activated by glutamatergic system and that these neurons express functional glutamate receptors.